CHRNA9 Antikörper (N-Term)
-
- Target Alle CHRNA9 Antikörper anzeigen
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio), Schwein, Fledermaus, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CHRNA9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- Human CHRNA9
- Homologie
- Percent identity by BLAST analysis: Dog, Bovine, Rabbit, Horse, Guinea pig (100%) Mouse (93%) Zebrafish (80%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide from N-Terminus of human CHRNA9 (Q9UGM1, NP_060051). Percent identity by BLAST analysis: Human, Chimpanzee, Gibbon, Monkey, Galago, Marmoset, Elephant, Panda, Dog, Bovine, Bat, Rabbit, Horse, Pig, Opossum, Guinea pig (100%), Mouse (93%), Zebra finch, Chicken, Xenopus, Trachemys (92%), Rat (86%), Turkey, Lizard (85%), Zebrafish (80%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product CHRNA9 Primärantikörper
-
-
- Applikationshinweise
-
Approved: IHC, IHC-P (5 μg/mL), WB (0.06 μg/mL)
Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 5 μg/mL. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
- Konzentration
- Lot specific
- Buffer
- Lyophilized.
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
- Andere Bezeichnung
- CHRNA9 (CHRNA9 Produkte)
- Synonyme
- HSA243342 antikoerper, NACHRA9 antikoerper, 2410015I05Rik antikoerper, Acra9 antikoerper, EG666827 antikoerper, Gm8311 antikoerper, cholinergic receptor nicotinic alpha 9 subunit antikoerper, cholinergic receptor, nicotinic, alpha polypeptide 9 antikoerper, CHRNA9 antikoerper, Chrna9 antikoerper
- Hintergrund
-
Name/Gene ID: CHRNA9
Subfamily: Nicotinic acetylcholine receptor
Family: Ion Channel
Synonyms: CHRNA9, AChR-alpha9, NACHR alpha 9, NACHRA9, HSA243342, NACHR alpha-9 - Gen-ID
- 55584
- NCBI Accession
- NP_060051
- UniProt
- Q9UGM1
- Pathways
- Sensory Perception of Sound
-